Trial
NCT04005209
Ketamine Infusion for Sickle Cell Pain Crisis
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Duke University
Collaborators
—
Condition
Anemia
Intervention
Ketamine
Why stopped
Decided not to open study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-01-14